INMB vs AMGN: Which Stock is Better?
Side-by-side comparison of Inmune Bio Inc and Amgen Inc in 2026
INMB
Inmune Bio Inc
$1.29
AMGN
Amgen Inc
$345.84
Key Metrics Comparison
| Metric | INMB | AMGN | Winner |
|---|---|---|---|
| Market Cap | $33.50M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | 2.6% | 0.1% | INMB |
| Gross Margin | 100.0% | 70.8% | INMB |
Analyze INMB
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INMB or AMGN a better investment?
Comparing INMB and AMGN: Inmune Bio Inc has a market cap of $33.50M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INMB and AMGN?
INMB (Inmune Bio Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INMB or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INMB or AMGN?
INMB has higher revenue growth at 2.6% vs 0.1% for AMGN.
Which company is more profitable: INMB or AMGN?
Inmune Bio Inc (INMB) has higher gross margins at 100.0% compared to 70.8% for AMGN.
Which is the larger company: INMB or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $33.50M for INMB.
Should I buy INMB or AMGN in 2026?
Both INMB and AMGN have investment merit. INMB trades at $1.29 while AMGN trades at $345.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INMB and AMGN stock?
Key differences: Market Cap ($33.50M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (2.6% vs 0.1%), Gross Margin (100.0% vs 70.8%).